Newbridge Financial Services Group’s Molecular Templates, Inc. MTEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-49
Closed -$310 1363
2023
Q3
$310 Sell
49
-1
-2% -$8 ﹤0.01% 1225
2023
Q2
$358 Hold
50
﹤0.01% 1272
2023
Q1
$283 Hold
50
﹤0.01% 1344
2022
Q4
$245 Hold
50
﹤0.01% 1382
2022
Q3
$1K Hold
50
﹤0.01% 1365
2022
Q2
$1K Hold
50
﹤0.01% 1332
2022
Q1
$3K Hold
50
﹤0.01% 1255
2021
Q4
$3K Sell
50
-2
-4% -$150 ﹤0.01% 1203
2021
Q3
$5K Hold
52
﹤0.01% 1032
2021
Q2
$6K Hold
52
﹤0.01% 1107
2021
Q1
$10K Hold
52
0.01% 913
2020
Q4
$7K Buy
+52
New +$7.68K 0.01% 803

Other funds holding MTEM

Newbridge Financial Services Group's MTEM Position: Q4 2023 in Review

Newbridge Financial Services Group sold out of Molecular Templates, Inc. (MTEM) in Q4 2023, closing a stake of 49 shares — an estimated $310 sold.

Newbridge Financial Services Group first reported a position in MTEM in Q4 2020 and held it in 12 quarters. The position peaked at $10K in Q1 2021. 29 funds tracked by Wall St. Rank hold MTEM as of Q4 2023.

  • Newbridge Financial Services Group reported no remaining Molecular Templates, Inc. position as of Q4 2023 after selling out during the quarter.
  • Newbridge Financial Services Group sold 49 Molecular Templates, Inc. shares in Q4 2023, an estimated $310.
  • Newbridge Financial Services Group first reported a position in Molecular Templates, Inc. in Q4 2020 and held it in 12 quarters.
  • Newbridge Financial Services Group's Molecular Templates, Inc. position peaked at $10K in Q1 2021.
  • 29 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q4 2023.

Based on Newbridge Financial Services Group's 13F filing for Q4 2023, filed 28 Mar 2024.